Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Market sentiment signals for Aclaris Therapeutics (ACRS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
16 analysts
Options Flow (P/C)
—
Avg Consensus PT
$11
+64.7%
Highest Price Target
$22
+239.0%
Lowest Price Target
$1
-84.6%
Short Interest
10.6%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | LifeSci Capital | —— | +100.3% | $13 | Initiate | Outperform |
| May 5, 2026 | Piper Sandler | Biren Amin— | +69.5% | $7 → $11 | Maintained | Overweight |